Martin Schlattjan

2.2k total citations · 1 hit paper
34 papers, 1.6k citations indexed

About

Martin Schlattjan is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Martin Schlattjan has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 15 papers in Hepatology and 9 papers in Surgery. Recurrent topics in Martin Schlattjan's work include Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (7 papers) and Liver physiology and pathology (4 papers). Martin Schlattjan is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (7 papers) and Liver physiology and pathology (4 papers). Martin Schlattjan collaborates with scholars based in Germany, United States and Türkiye. Martin Schlattjan's co-authors include Ali Canbay, Guido Gerken, Jan‐Peter Sowa, Lars P. Bechmann, Alexander Wree, Ariel E. Feldstein, Hideo A. Baba, Hongying Li, Matthew D. McGeough and Carla A. Peña and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Martin Schlattjan

34 papers receiving 1.5k citations

Hit Papers

NLRP3 inflammasome activation is required for fibrosis de... 2014 2026 2018 2022 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NLRP3 inflammasome activation is required for fibrosis development in NAFLD
    2014 404 citations Alexander Wree, Matthew D. McGeough et al. Journal of Molecular Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Schlattjan Germany 17 1.1k 561 387 289 271 34 1.6k
Angelo H. Paredes United States 12 1.0k 0.9× 461 0.8× 333 0.9× 285 1.0× 386 1.4× 29 1.3k
Monika Rau Germany 21 1.1k 1.0× 390 0.7× 553 1.4× 227 0.8× 359 1.3× 44 1.7k
Alişan Kahraman Germany 19 900 0.8× 545 1.0× 294 0.8× 300 1.0× 153 0.6× 62 1.4k
Ariel E. Feldstein United States 15 958 0.9× 544 1.0× 680 1.8× 237 0.8× 240 0.9× 23 1.7k
Adam Sheka United States 12 898 0.8× 334 0.6× 315 0.8× 344 1.2× 326 1.2× 21 1.3k
Michiharu Komatsu Japan 27 1.4k 1.3× 970 1.7× 332 0.9× 400 1.4× 254 0.9× 66 1.9k
Takefumi Kimura Japan 22 932 0.9× 609 1.1× 317 0.8× 343 1.2× 217 0.8× 102 1.5k
Geoff Farrell Australia 11 1.2k 1.2× 516 0.9× 310 0.8× 216 0.7× 490 1.8× 15 1.5k
Javier Ampuero Spain 24 1.2k 1.1× 849 1.5× 290 0.7× 397 1.4× 242 0.9× 115 1.7k
Melanie Beaton Canada 20 1.3k 1.2× 684 1.2× 312 0.8× 281 1.0× 380 1.4× 41 1.9k

Countries citing papers authored by Martin Schlattjan

Since Specialization
Citations

This map shows the geographic impact of Martin Schlattjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Schlattjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Schlattjan more than expected).

Fields of papers citing papers by Martin Schlattjan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Schlattjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Schlattjan. The network helps show where Martin Schlattjan may publish in the future.

Co-authorship network of co-authors of Martin Schlattjan

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Schlattjan. A scholar is included among the top collaborators of Martin Schlattjan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Schlattjan. Martin Schlattjan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Werner, Franziska, Katharina Völker, Marco Abeßer, et al.. (2023). Ablation of C-type natriuretic peptide/cGMP signaling in fibroblasts exacerbates adverse cardiac remodeling in mice. JCI Insight. 8(13). 7 indexed citations
2.
Mazzolini, Guillermo, Catalina Atorrasagasti, Estanislao Peixoto, et al.. (2018). SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease. Scientific Reports. 8(1). 725–725. 27 indexed citations
3.
Schreiter, Thomas, Jan‐Peter Sowa, Martin Schlattjan, et al.. (2016). Human Ex-Vivo Liver Model for Acetaminophen-induced Liver Damage. Scientific Reports. 6(1). 31916–31916. 16 indexed citations
4.
Manka, Paul, Lars P. Bechmann, Jason D. Coombes, et al.. (2015). Hepatitis E Virus Infection as a Possible Cause of Acute Liver Failure in Europe. Clinical Gastroenterology and Hepatology. 13(10). 1836–1842.e2. 72 indexed citations
5.
Beilfuss, A, Jan‐Peter Sowa, Svenja Sydor, et al.. (2014). Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. Gut. 64(5). 791–799. 120 indexed citations
6.
Dechêne, Alexander, Jan‐Peter Sowa, Martin Schlattjan, et al.. (2014). Mini-Laparoscopy Guided Liver Biopsy Increases Diagnostic Accuracy in Acute Liver Failure. Digestion. 90(4). 240–247. 16 indexed citations
7.
Wree, Alexander, Matthew D. McGeough, Carla A. Peña, et al.. (2014). NLRP3 inflammasome activation is required for fibrosis development in NAFLD. Journal of Molecular Medicine. 92(10). 1069–1082. 404 indexed citations breakdown →
8.
Manka, Paul, Lars P. Bechmann, Martin Schlattjan, et al.. (2014). Low Levels of Blood Lipids Are Associated with Etiology and Lethal Outcome in Acute Liver Failure. PLoS ONE. 9(7). e102351–e102351. 22 indexed citations
9.
Wree, Alexander, Martin Schlattjan, Lars P. Bechmann, et al.. (2014). Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients. Metabolism. 63(12). 1542–1552. 86 indexed citations
10.
Landgraeber, Stefan, Martin Schlattjan, Lars P. Bechmann, et al.. (2013). Adiponectin attenuates osteolysis in aseptic loosening of total hip replacements. Acta Biomaterialia. 10(1). 384–393. 15 indexed citations
11.
Manka, Paul, Lars P. Bechmann, Frank Tacke, et al.. (2013). Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure. BMC Gastroenterology. 13(1). 58–58. 11 indexed citations
12.
Demir, Münevver, Sonja Lang, Martin Schlattjan, et al.. (2013). NIKEI: A New Inexpensive and Non-Invasive Scoring System to Exclude Advanced Fibrosis in Patients with NAFLD. PLoS ONE. 8(3). e58360–e58360. 35 indexed citations
13.
Fingas, Christian D., Akif Altınbaş, Martin Schlattjan, et al.. (2013). Expression of Apoptosis- and Vitamin D Pathway-Related Genes in Hepatocellular Carcinoma. Digestion. 87(3). 176–181. 17 indexed citations
14.
Kahraman, Alişan, Jan‐Peter Sowa, Martin Schlattjan, et al.. (2013). Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients. Clinical Science. 125(8). 391–400. 52 indexed citations
15.
Schlattjan, Martin, et al.. (2013). 1255 miR-101 IN STEATOSIS AND STEATOHEPATITIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). Journal of Hepatology. 58. S508–S508. 3 indexed citations
16.
Sydor, Svenja, Yanli Gu, Martin Schlattjan, et al.. (2012). Steatosis does not impair liver regeneration after partial hepatectomy. Laboratory Investigation. 93(1). 20–30. 43 indexed citations
17.
Elfimova, N, Martin Schlattjan, Jan‐Peter Sowa, et al.. (2012). Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis. Frontiers in Physiology. 3. 476–476. 36 indexed citations
18.
Dechêne, Alexander, Jan‐Peter Sowa, Robert K. Gieseler, et al.. (2010). Acute Liver Failure Is Associated With Elevated Liver Stiffness and Hepatic Stellate Cell Activation†. Hepatology. 52(3). 1008–1016. 123 indexed citations
19.
Gieseler, Robert K., G. Marquitan, Martin Schlattjan, et al.. (2010). Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C. Journal of Viral Hepatitis. 18(11). 760–767. 25 indexed citations
20.
Kahraman, Alişan, Martin Schlattjan, Peri Kocabayoglu, et al.. (2009). Major Histocompatibility Complex Class I–Related Chains A and B (Mic A/B): A Novel Role in Nonalcoholic Steatohepatitis. Hepatology. 51(1). 92–102. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelo H. Paredes Breakdown of academic impact, for papers by Monika Rau Breakdown of academic impact, for papers by Alişan Kahraman Breakdown of academic impact, for papers by Ariel E. Feldstein Breakdown of academic impact, for papers by Adam Sheka Breakdown of academic impact, for papers by Michiharu Komatsu Breakdown of academic impact, for papers by Takefumi Kimura Breakdown of academic impact, for papers by Geoff Farrell Breakdown of academic impact, for papers by Javier Ampuero Breakdown of academic impact, for papers by Melanie Beaton
Rankless by CCL
2026